Frédéric Forget
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 7
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 7
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Fernando Rivera (3 shared papers)Xuesong Guan (2 shared papers)Gaston Demonty (3 shared papers)Meinolf Karthaus (3 shared papers)Isabel Sevilla (1 shared paper)J. Randolph Hecht (1 shared paper)Gianpiero Fasola (1 shared paper)Lee S. Schwartzberg (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Annals of Oncology (4 papers)Clinical Cancer Research (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Cancer Medicine (2 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Frédéric Forget
34 papers receiving 501 citations
Peers
Comparison fields: 5 of 62
- Oncology 251
- Hepatology 67
- Hematology 86
- Family Practice 12
- Pulmonary and Respiratory Medicine 166
Countries citing papers authored by Frédéric Forget
This map shows the geographic impact of Frédéric Forget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Forget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Forget more than expected).
Fields of papers citing papers by Frédéric Forget
This network shows the impact of papers produced by Frédéric Forget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Forget. The network helps show where Frédéric Forget may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Forget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 79 | |
| 2 | 2012 | 64 | |
| 3 | 2014 | 39 | |
| 4 | 2013 | 37 | |
| 5 | 2017 | 36 | |
| 6 | A phase I, clinical and pharmacokinetic (PK) trial of the farnesyl transferase inhibitor (FTI) R115777 + docetaxel : a promising combination in patients (pts) with solid tumors | 2001 | 36 |
| 7 | Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study. | 2011 | 30 |
| 8 | 2021 | 24 | |
| 9 | 2015 | 18 | |
| 10 | 2020 | 17 | |
| 11 | 2023 | 17 | |
| 12 | 2018 | 14 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2001 | 11 | |
| 16 | 2014 | 8 | |
| 17 | 2005 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2001 | 5 |
About Frédéric Forget
Frédéric Forget is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 37 papers that have together received 516 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Advanced Breast Cancer Therapies (7 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Immunotherapy and Immune Responses (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (251 citations), Hepatology (67 citations), Hematology (86 citations), Family Practice (12 citations) and Pulmonary and Respiratory Medicine (166 citations). Frédéric Forget has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Fernando Rivera, Xuesong Guan, Gaston Demonty, Meinolf Karthaus, Isabel Sevilla, J. Randolph Hecht, Gianpiero Fasola, Lee S. Schwartzberg, Howard Safran and Jean-Luc Canon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.